Anwei Te (安威特)安威特
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 山东华鲁制药有限公司Chinese legal name: 山东华鲁制药有限公司
主要成分Active Ingredients
- 法莫替丁famotidine
药物知识说明
法莫替丁是一种在国家药监局注册认定的药品。该药品含有法莫替丁-cafb7bbf等成分。
该药品关联的活性成分包括：法莫替丁famotidine。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：山东华鲁制药有限公司Chinese legal name: 山东华鲁制药有限公司。
您可以探索含有相同成分的其他药品：法莫替丁-cafb7bbf成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
famotidine is a medicine registered with the national drug regulatory authority. It contains famotidine as active ingredient(s).
Active ingredients associated with this product: famotidinefamotidine.
Manufacturers recorded for this product: 山东华鲁制药有限公司Chinese legal name: 山东华鲁制药有限公司.
Explore other medicines containing the same ingredient: famotidine products.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 安威特Recorded Chinese name: 安威特
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 100ml:法莫替丁20mg与葡萄糖5gRecorded Chinese specification: 100ml:法莫替丁20mg与葡萄糖5g
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 山东华鲁制药有限公司Chinese legal name: 山东华鲁制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20030806
相关问题Questions
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20030806
Manufacturer
Chinese legal name: 山东华鲁制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20030806
生产企业
山东华鲁制药有限公司(国产)
适应症
本品治疗消化性溃疡、急性应激性溃疡和出血性胃炎所致的上消化道出血、卓-艾氏综合症;预防侵袭性应激反应(各种大手术，如:脑血管障碍、头部外伤、多脏器衰竭、大面积烧伤等)引起的上消化道出血。
用法用量
缓慢静滴。每次20mg(1瓶)，每日2次(间隔12小时)，疗程5天。一旦病情许可，应迅速将静脉给药改为口服给药。
不良反应
1.少有头痛、头晕、便秘和腹泻，发生率分别为4.7%?1.2%?1.2%和1.7%
2.偶见皮疹、荨麻疹(应停药)?白细胞减少、氨基转移酶升高等;罕见腹部胀满感、食欲不振及心率增加、血压上升、颜面潮红、月经不调等.
禁忌
1.对本品过敏者禁用。
2.与同类药有交叉过敏现象，对H2受体拮抗剂过敏者禁用。
3.严重肾功能不全及孕妇、哺乳期妇女禁用。
注意事项
1.本品会隐蔽胃癌症状，故应在排除肿瘤和食道胃底静脉曲张后再给药.
2.有肝肾功能不全者慎用.
贮藏
密封，置阴凉处。
规格
100ml:法莫替丁20mg与葡萄糖5g
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.